SCHEMBL4073736

SCHEMBL4073736

C[C@@H]1CC(C#N)(c2cc(F)ccc2-c2ccc(S(C)(=O)=O)cc2)[C@H](Cc2ccccc2)CN1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.38
DRD1 P21728 1/20 0.36
PTGS1 P23219 4/20 0.35
TDO2 P48775 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3856818 0.88 CTSC (0.33)
SCHEMBL3838661 0.73 SIGMAR1 (0.41) PTGS2PTGS1
SCHEMBL3479537 0.73 SIGMAR1 (0.41) PTGS2PTGS1
SCHEMBL8172292 0.66 PTGS2 (0.39) PTGS2PTGS1
SCHEMBL13411170 0.66 PTGS2 (0.39) PTGS2PTGS1
SCHEMBL8179365 0.61 PTGS2 (0.41) PTGS2PTGS1
SCHEMBL13448493 0.60 PTGS2 (0.72) PTGS2PTGS1TDO2
SCHEMBL215130 0.59 PTGS2 (1.00) PTGS2DRD1PTGS1
SCHEMBL2816588 0.57 PTGS2 (0.63) PTGS2TDO2
SCHEMBL5723692 0.57 PTGS2 (0.56) PTGS2DRD1PTGS1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2063889-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-06-03 EP disclosed
WO-2008030412-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-13 WO disclosed